IPP Bureau
European Commission approves Roche’s Gavreto
By IPP Bureau - November 22, 2021
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
Amneal gets approval for Difluprednate ophthalmic emulsion
By IPP Bureau - November 22, 2021
The company is moving towards complex and more differentiated products
FDA grants Theradaptive Breakthrough Medical Device designation
By IPP Bureau - November 22, 2021
Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications
HCG acquires Suchirayu Healthcare Solutions
By IPP Bureau - November 22, 2021
Suchirayu owns a state-of-the-art multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds
Merck showcases potential for several cancers, MS and lupus
By IPP Bureau - November 22, 2021
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
Funding push to pharma R&D critical for unleashing next phase of growth
By IPP Bureau - November 20, 2021
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Laurus Labs acquires stake in IIT Bombay incubated ImmunoACT
By IPP Bureau - November 20, 2021
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
Flipkart acquires SastaSundar, an online pharmacy and healthcare platform
By IPP Bureau - November 20, 2021
Flipkart also announced its foray into the healthcare sector through the launch of Flipkart Health+
U.S. FDA grants breakthrough designation to Datar’s blood test to detect breast cancer
By IPP Bureau - November 20, 2021
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
Oravax and Genomma JV to commercialise Covid-19 vaccine in Mexico and Latam
By IPP Bureau - November 20, 2021
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
U.S. FDA allows Pfizer and Moderna booster doses for all
By IPP Bureau - November 20, 2021
This is a shot in the arm for the vaccine manufacturers
Novo Nordisk to acquire Dicerna Pharmaceuticals for US $ 3.3 bn
By IPP Bureau - November 20, 2021
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
U.S. FDA approves first drug to improve growth in kids with most common form of dwarfism
By IPP Bureau - November 20, 2021
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
Natco launches Tipanat tablets in India
By IPP Bureau - November 19, 2021
It is used for the treatment of advanced colorectal and gastric cancer
CIMS multi super specialty hospital performs 150 bone marrow transplants
By IPP Bureau - November 19, 2021
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
